Ocean Biomedical, Inc. (OCEA)
OCEA Stock Price Chart
Explore Ocean Biomedical, Inc. interactive price chart. Choose custom timeframes to analyze OCEA price movements and trends.
OCEA Company Profile
Discover essential business fundamentals and corporate details for Ocean Biomedical, Inc. (OCEA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
8 Nov 2021
Employees
7.00
Website
http://www.oceanbiomedical.comCEO
Inderjote Kathuria
Description
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP, as well as a product candidate for the treatment of COVID-19 in hospitalized patients. The company was incorporated in 2019 and is based in Providence, Rhode Island.
OCEA Financial Timeline
Browse a chronological timeline of Ocean Biomedical, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 8 Apr 2025
EPS came in at $0.02 .
Earnings released on 13 Jan 2025
EPS came in at -$0.20 surpassing the estimated -$0.23 by +13.04%.
Earnings released on 23 Dec 2024
EPS came in at -$0.63 falling short of the estimated -$0.19 by -231.58%.
Earnings released on 27 Sept 2024
EPS came in at -$0.63 falling short of the estimated -$0.22 by -184.99%.
Earnings released on 15 Apr 2024
EPS came in at -$0.53 falling short of the estimated -$0.15 by -253.33%.
Earnings released on 28 Feb 2024
Earnings released on 29 Sept 2023
EPS came in at -$0.53 falling short of the estimated -$0.15 by -252.99%.
Earnings released on 14 Aug 2023
EPS came in at -$0.39 falling short of the estimated -$0.20 by -95.00%.
Earnings released on 1 May 2023
EPS came in at $0.43 surpassing the estimated -$0.16 by +368.75%.
Earnings released on 15 Feb 2023
EPS came in at $0.03 .
Earnings released on 17 Oct 2022
EPS came in at -$0.08 .
Earnings released on 11 Jul 2022
EPS came in at -$0.73 .
Earnings released on 25 Apr 2022
EPS came in at -$0.27 .
Earnings released on 31 Dec 2021
EPS came in at -$0.62 .
Earnings released on 30 Sept 2021
EPS came in at -$0.36 .
Earnings released on 30 Jun 2021
EPS came in at -$0.40 .
Earnings released on 31 Mar 2021
EPS came in at -$1.35 .
Earnings released on 31 Dec 2020
EPS came in at -$0.04 .
OCEA Stock Performance
Access detailed OCEA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.